Vilnius, Lithuania, March 20, 2025 – Northway Biotech ("NBT"), a Contract Development and Manufacturing Organization (CDMO), is proud to be recognized as winners of the Outsourced Pharma and Life Science Connect 2025 CDMO Leadership Awards in the Global Biologics CDMO category.
This recognition is based on feedback from industry professionals who evaluated CDMOs they have worked with directly. Winners were selected through a comprehensive assessment process that measured overall customer satisfaction, performance, and reliability - highlighting those CDMOs that consistently deliver exceptional value across key service areas.
Prof. Vladas Bumelis, CEO of Northway Biotech, expressed his thoughts on the recognition: “This award reflects the trust our partners have in our team, the scientific excellence we pursue, and our commitment to supporting the development and manufacturing of biologics. We are proud to be recognized as one of the top global CDMOs, and we will continue to provide flexible, high-quality solutions that facilitate the delivery of innovative therapies to patients worldwide.”
“We are thrilled to introduce our 2025 CDMO Leadership Awards winners to the Outsourcing community, and honored to offer such an important tool for drug sponsors in selecting their best-fit partner to help bring life-saving therapies to market,” says Louis Garguilo, Chief Editor at Outsourced Pharma. “The new categories and enhanced scoring methodology that went into this year’s appraisal bring an improved experience for drug sponsors using the resource as well as an ever-so-coveted distinction for the CDMOs.”
About Northway Biotech
Northway Biotech is a leading contract development and manufacturing organization (CDMO) supporting customers worldwide. Its highly experienced and professional team executes projects at every stage, from cell line construction and process development to cGMP manufacturing of biopharmaceutical products. The company's extensive expertise and vertically integrated service offering enables rapid execution of multiple projects from its state-of-the-art GMP facilities while ensuring full process and product compliance at all stages of research, development, and commercial manufacturing. Northway Biotech is a privately owned company founded in 2004 and operates locations in Vilnius, Lithuania; London, United Kingdom; and Waltham, MA, USA.
Northway Biotech Contact:
Vladas Algirdas Bumelis
CEO and Chairman of the Board
vladas.bumelis@northwaybiotech.com